Literature DB >> 10370908

Functional imaging of Parkinson's disease: is it possible to detect brain areas for specific symptoms?

D J Brooks1.   

Abstract

H2(15)O PET activation studies enable the brain systems involved in controlling different aspects of motor function to be defined. In Parkinson's disease (PD) freely chosen limb movements are performed slowly. This bradykinesia is associated with selective underactivity of the supplementary motor area and dorsal prefrontal cortex, frontal association areas that receive subcortical input principally from the basal ganglia. At the same time there is compensatory overactivity of the lateral premotor and parietal cortex, areas that have a primary role in facilitating motor responses to visual and auditory cues. This finding explains why PD patients find it easier to perform cued as opposed to freely chosen actions. Levels of activation of the supplementary motor area and dorsal prefrontal cortex in PD can be restored with dopaminergic medication, implants of fetal mesencephalic tissue, internal pallidotomy or high frequency electrical subthalamic stimulation. Activation studies suggest that Parkinsonian rest tremor arises from a combination of inappropriate overactivity of cerebellar connections and loss of dopaminergic function. When tremor is relieved by ventral thalamotomy or thalamic stimulation this cerebellar overactivity is corrected but at the expense of reducing levels of primary motor cortex activation. It has been hypothesised that dyskinesias in PD arise due to altered dopamine receptor binding following chronic exposure to levodopa stimulation. Functional imaging findings, however, are against this hypothesis and rather suggest that downstream increases in basal ganglia opioid neurotransmission are more likely to be relevant.

Entities:  

Mesh:

Year:  1999        PMID: 10370908     DOI: 10.1007/978-3-7091-6360-3_8

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  6 in total

1.  Differential degradation of motor deficits during gradual dopamine depletion with 6-hydroxydopamine in mice.

Authors:  A M Willard; R S Bouchard; A H Gittis
Journal:  Neuroscience       Date:  2015-06-09       Impact factor: 3.590

2.  Correlates of movement initiation and velocity in Parkinson's disease: A longitudinal PET study.

Authors:  Maren Carbon; M Felice Ghilardi; Vijay Dhawan; David Eidelberg
Journal:  Neuroimage       Date:  2006-10-24       Impact factor: 6.556

3.  Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease.

Authors:  Jennifer L Whitwell; Stephen D Weigand; Maria M Shiung; Bradley F Boeve; Tanis J Ferman; Glenn E Smith; David S Knopman; Ronald C Petersen; Eduardo E Benarroch; Keith A Josephs; Clifford R Jack
Journal:  Brain       Date:  2007-01-31       Impact factor: 13.501

Review 4.  Current role of functional MRI in the diagnosis of movement disorders.

Authors:  Fatta B Nahab; Mark Hallett
Journal:  Neuroimaging Clin N Am       Date:  2010-02       Impact factor: 2.264

5.  Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach.

Authors:  S J G Lewis; T Foltynie; A D Blackwell; T W Robbins; A M Owen; R A Barker
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-03       Impact factor: 10.154

6.  Mapping dopamine function in primates using pharmacologic magnetic resonance imaging.

Authors:  Bruce G Jenkins; Rosario Sanchez-Pernaute; Anna-Liisa Brownell; Yin-Ching Iris Chen; Ole Isacson
Journal:  J Neurosci       Date:  2004-10-27       Impact factor: 6.709

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.